In Vivo Detection of Neurofibrillary Tangles by 18 F-MK-6240 PET/MR in Patients With Ischemic Stroke
The risk of developing Alzheimer disease is increased after stroke, and this association may not solely be driven by traditional vascular risk factors. Neuronal death leads to the release of tau proteins, which can become dephosphorylated, rephosphorylated, or hyperphosphorylated in the setting of i...
Saved in:
Published in | Neurology Vol. 100; no. 1; p. e62 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
03.01.2023
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | The risk of developing Alzheimer disease is increased after stroke, and this association may not solely be driven by traditional vascular risk factors. Neuronal death leads to the release of tau proteins, which can become dephosphorylated, rephosphorylated, or hyperphosphorylated in the setting of ischemia, possibly leading to formation of neurofibrillary tangles (NFT). Therefore, a potential synergistic effect between development of tauopathy and cerebrovascular lesion burden may contribute to cognitive decline after stroke. We explored the spatial and temporal distribution of NFT after ischemic stroke in vivo by using
F-MK-6240 PET.
We included patients with a first ischemic stroke to undergo longitudinal
F-MK-6240 PET/MR within 2-4 weeks and 6 months after stroke. For cross-sectional analyses, we also included age-matched healthy controls. We delineated 5 volumes of interest based on T2 FLAIR and T1 MR data: the ischemic lesion, 3 consecutive peri-ischemic areas, and the remaining ipsilesional hemisphere. We performed region-based voxel-wise partial volume correction on the PET data and calculated standardized uptake value ratios (SUVRs) with the cerebellum as the reference region.
We did not quantify PET scans of patients within the first month after stroke (n = 17; median age 73 years [interquartile range {IQR}: 62-82 years]) because the signal intensity was influenced by blood-brain barrier breakdown hampering a reliable data analysis. At 6 months after the event (n = 13; median age 71 years [IQR: 60-79 years]),
F-MK-6240 SUVR was increased in the ischemic lesion compared with 20 age-matched healthy controls (median age 71.5 years [IQR: 66-76 years]; ratio
= 1.62 ± 0.54; 1-sample
test:
= 0.0015) and gradually decreased in the surrounding tissue (1-way within-subject analysis of variance [F{1.2, 14.8} = 18.0,
= 0.00043]).
These findings suggest that NFT may form after ischemic stroke and spread in the peri-ischemic brain parenchyma. Further follow-up is required to gain more insight into the spatial and temporal dynamics of this tauopathy after ischemic stroke. |
---|---|
AbstractList | The risk of developing Alzheimer disease is increased after stroke, and this association may not solely be driven by traditional vascular risk factors. Neuronal death leads to the release of tau proteins, which can become dephosphorylated, rephosphorylated, or hyperphosphorylated in the setting of ischemia, possibly leading to formation of neurofibrillary tangles (NFT). Therefore, a potential synergistic effect between development of tauopathy and cerebrovascular lesion burden may contribute to cognitive decline after stroke. We explored the spatial and temporal distribution of NFT after ischemic stroke in vivo by using
F-MK-6240 PET.
We included patients with a first ischemic stroke to undergo longitudinal
F-MK-6240 PET/MR within 2-4 weeks and 6 months after stroke. For cross-sectional analyses, we also included age-matched healthy controls. We delineated 5 volumes of interest based on T2 FLAIR and T1 MR data: the ischemic lesion, 3 consecutive peri-ischemic areas, and the remaining ipsilesional hemisphere. We performed region-based voxel-wise partial volume correction on the PET data and calculated standardized uptake value ratios (SUVRs) with the cerebellum as the reference region.
We did not quantify PET scans of patients within the first month after stroke (n = 17; median age 73 years [interquartile range {IQR}: 62-82 years]) because the signal intensity was influenced by blood-brain barrier breakdown hampering a reliable data analysis. At 6 months after the event (n = 13; median age 71 years [IQR: 60-79 years]),
F-MK-6240 SUVR was increased in the ischemic lesion compared with 20 age-matched healthy controls (median age 71.5 years [IQR: 66-76 years]; ratio
= 1.62 ± 0.54; 1-sample
test:
= 0.0015) and gradually decreased in the surrounding tissue (1-way within-subject analysis of variance [F{1.2, 14.8} = 18.0,
= 0.00043]).
These findings suggest that NFT may form after ischemic stroke and spread in the peri-ischemic brain parenchyma. Further follow-up is required to gain more insight into the spatial and temporal dynamics of this tauopathy after ischemic stroke. |
Author | Thijs, Liselot Michiels, Laura Verheyden, Geert Koole, Michel Van Laere, Koen Mertens, Nathalie Sunaert, Stefan Vandenbulcke, Mathieu Bormans, Guy Lemmens, Robin |
Author_xml | – sequence: 1 givenname: Laura orcidid: 0000-0002-1208-5334 surname: Michiels fullname: Michiels, Laura email: laura.michiels@uzleuven.be organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium. laura.michiels@uzleuven.be – sequence: 2 givenname: Liselot surname: Thijs fullname: Thijs, Liselot organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium – sequence: 3 givenname: Nathalie orcidid: 0000-0002-2409-7586 surname: Mertens fullname: Mertens, Nathalie organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium – sequence: 4 givenname: Stefan orcidid: 0000-0002-1177-4680 surname: Sunaert fullname: Sunaert, Stefan organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium – sequence: 5 givenname: Mathieu surname: Vandenbulcke fullname: Vandenbulcke, Mathieu organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium – sequence: 6 givenname: Guy orcidid: 0000-0002-0335-7190 surname: Bormans fullname: Bormans, Guy organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium – sequence: 7 givenname: Geert orcidid: 0000-0003-3095-8175 surname: Verheyden fullname: Verheyden, Geert organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium – sequence: 8 givenname: Michel surname: Koole fullname: Koole, Michel organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium – sequence: 9 givenname: Koen surname: Van Laere fullname: Van Laere, Koen organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium – sequence: 10 givenname: Robin orcidid: 0000-0002-4948-5956 surname: Lemmens fullname: Lemmens, Robin organization: From the Department of Neurosciences (L.M., S.S., M.V., R.L.), Leuven Brain Institute, Belgium; VIB, Center for Brain & Disease Research (L.M., R.L), Laboratory of Neurobiology, Belgium; Department of Neurology (L.M., R.L.), University Hospitals Leuven, Belgium; Department of Rehabilitation Sciences (L.T., G.V.), KU Leuven, Belgium; Nuclear Medicine and Molecular Imaging (N.M., M.K., K.V.L.), Department of Imaging and Pathology, KU Leuven, Belgium; Translational MRI (S.S.), Department of Imaging and Pathology, KU Leuven, Belgium; Department of Radiology (S.S.), University Hospitals Leuven, Belgium; Department of Geriatric Psychiatry (M.V.), University Psychiatric Centre, KU Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences (G.B.), KU Leuven, Belgium; and Division of Nuclear Medicine (K.V.L.), University Hospitals Leuven, Belgium |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36302665$$D View this record in MEDLINE/PubMed |
BookMark | eNo9T21PwjAYbIxGXvQfGPP8gUH7dCvtR4Ogi4BEUfxG2q2V6ujINkz49y7x5b7c5S653PXIaSiDJeSK0QFDhsP1Yjag_0DKeByfkC5LUESC41uH9Or6g9LWGKlz0uGCUxQi6ZI8DfDqv0q4tY3NGl8GKB0s7KEqnTeVLwpdHWGlw3thazBHYBKm0fwhEhhTWE5Ww_kT-ABL3XgbmhrWvtlCWmdbu_MZPDdV-WkvyJnTRW0vf7lPXqaT1fg-mj3epeObWZQxEdMo5ioRI-swyyVTimnllBV5rIyiQhjJ2wg5OimtRqeolLlCjUnSasONxT65_undH8zO5pt95Xft_M3fXfwGFY5VXw |
CitedBy_id | crossref_primary_10_1002_smll_202409713 crossref_primary_10_1089_neu_2023_0085 crossref_primary_10_3390_cells12232763 crossref_primary_10_1002_acn3_52247 |
ContentType | Journal Article |
Copyright | 2022 American Academy of Neurology. |
Copyright_xml | – notice: 2022 American Academy of Neurology. |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1212/WNL.0000000000201344 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1526-632X |
ExternalDocumentID | 36302665 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -~X .XZ .Z2 01R 0R~ 123 1J1 29N 354 3PY 4Q1 4Q2 4Q3 53G 5RE 5VS 6PF 77Y AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAWTL AAXQO AAYEP ABBLC ABIVO ABJNI ABOCM ABVCZ ACDDN ACGFS ACIJW ACILI ACLDA ACOAL ACWRI ACXJB ADGGA AE6 AEBDS AENEX AFDTB AFEXH AFUWQ AGINI AHOMT AHQNM AHVBC AIJEX AJCLO AKCTQ AKULP AKWKN ALMA_UNASSIGNED_HOLDINGS AMJPA AMKUR AMNEI AOHHW AWKKM BOYCO BQLVK BYPQX C45 CGR CS3 CUY CVF DIWNM DU5 E.X EBS ECM EIF EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG GQDEL HZ~ IKYAY IN~ IPNFZ JF7 KD2 KMI L-C L7B N9A NPM N~7 N~B O9- OAG OAH OBH ODMTH OHH OHYEH OJAPA OL1 OLB OLH OLU OLV OLW OLY OLZ OPX OVD OVDNE OVIDH OVLEI OWU OWV OWW OWX OWY OWZ OXXIT P2P RHI RIG RLZ RXW SJN TEORI V2I VVN W3M WH7 WOQ WOW XSW XXN XYM XYN YBU YCJ YFH ~9M |
ID | FETCH-LOGICAL-c1640-439567ef2cd81991a9f9e6d49b9066b83ef2232f88ea2f9088d92a255f90b3be2 |
IngestDate | Wed Feb 19 02:25:57 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2022 American Academy of Neurology. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1640-439567ef2cd81991a9f9e6d49b9066b83ef2232f88ea2f9088d92a255f90b3be2 |
ORCID | 0000-0002-2409-7586 0000-0002-1177-4680 0000-0003-3095-8175 0000-0002-4948-5956 0000-0002-0335-7190 0000-0002-1208-5334 |
PMID | 36302665 |
ParticipantIDs | pubmed_primary_36302665 |
PublicationCentury | 2000 |
PublicationDate | 2023-01-03 |
PublicationDateYYYYMMDD | 2023-01-03 |
PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-03 day: 03 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Neurology |
PublicationTitleAlternate | Neurology |
PublicationYear | 2023 |
SSID | ssj0015279 |
Score | 2.4099257 |
Snippet | The risk of developing Alzheimer disease is increased after stroke, and this association may not solely be driven by traditional vascular risk factors.... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | e62 |
SubjectTerms | Aged Aged, 80 and over Alzheimer Disease - pathology Cross-Sectional Studies Humans Ischemic Stroke - pathology Middle Aged Neurofibrillary Tangles - pathology Positron-Emission Tomography Stroke - pathology |
Title | In Vivo Detection of Neurofibrillary Tangles by 18 F-MK-6240 PET/MR in Patients With Ischemic Stroke |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36302665 |
Volume | 100 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELc6kKa9IL6_kR94i8zSJHXsR4Q2rUCmac1gb5Pj2LR8JFPJkMYfwN_Nne1kpRsI6EMU2aob-X45311_d0fIc4tF2rjKmckkZ5k2ApOVY5bHea6xwJly6dHFPt87yl4fT45Hox8rrKWzrnqhv1-ZV_I_UoUxkCtmyf6DZIdFYQDuQb5wBQnD9a9kPG2id4tvLSiNzuje9PPlNpDJDxJenkelaj58Nl_RzhyLaJcVbxiHAzY62Cnhl4tDjHgc-OqqSIbt5tEUPF7HmZ91y_bTL1wht_hqIB6ppAs4X_sc60HLl_PFRz-KDZ3agV1TmCWS5r1m7-bgBgzQmp01KqQQzTpjA25DSCJJXUjCqykT1GjCGU9do_QLPRvHlwDltabxCvmSNodjFTbi_f5bX2XSfcBgSX3FyBUBn35xEk55Ci6l7z3x59m1Gtv91AbZAG8D26dizCf8FzVJchmSLuGBtq96nC2y2S-x5p44M6W8SW4E_4K-9GC5RUamuU02i8CguEPqaUMRM3TADG0tXcMMDZih1TkdCzpghgJmtotDumhojxiKiKE9YqhHzF1ytLtTvtpjodMG0-Auxwys0gnPjU10LZALp6SVhteZrCSYpJVIYQpMbyuEUYlFalwtEwXeKNxXaWWSe-Ra0zbmAaFKxnGtpNbwqsP3xzIbC_BxU50JozPLH5L7fn9OTn05lZN-5x79duYx2bqA2RNy3cL7a56CMdhVz5ysfgJbl1c_ |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+Vivo+Detection+of+Neurofibrillary+Tangles+by+18+F-MK-6240+PET%2FMR+in+Patients+With+Ischemic+Stroke&rft.jtitle=Neurology&rft.au=Michiels%2C+Laura&rft.au=Thijs%2C+Liselot&rft.au=Mertens%2C+Nathalie&rft.au=Sunaert%2C+Stefan&rft.date=2023-01-03&rft.eissn=1526-632X&rft.volume=100&rft.issue=1&rft.spage=e62&rft_id=info:doi/10.1212%2FWNL.0000000000201344&rft_id=info%3Apmid%2F36302665&rft_id=info%3Apmid%2F36302665&rft.externalDocID=36302665 |